111 related articles for article (PubMed ID: 33120493)
21. Ultraviolet Irradiation of Skin Alters the Faecal Microbiome Independently of Vitamin D in Mice.
Ghaly S; Kaakoush NO; Lloyd F; Gordon L; Forest C; Lawrance IC; Hart PH
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30103486
[TBL] [Abstract][Full Text] [Related]
22. [Immunotherapy and Pharmaceutical Care for Non-small-cell Lung Cancer Complicated with Hyperthyroidism:Report of One Case].
Shen Z; Cao GW; Wang J; Pan J; Shi AM; Zhu Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):132-135. PubMed ID: 32131953
[TBL] [Abstract][Full Text] [Related]
23. Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
Toi Y; Sugawara S; Sugisaka J; Ono H; Kawashima Y; Aiba T; Kawana S; Saito R; Aso M; Tsurumi K; Suzuki K; Shimizu H; Domeki Y; Terayama K; Nakamura A; Yamanda S; Kimura Y; Honda Y
JAMA Oncol; 2019 Mar; 5(3):376-383. PubMed ID: 30589930
[TBL] [Abstract][Full Text] [Related]
24. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
Suzuki Y; Inui N; Karayama M; Imokawa S; Yamada T; Yokomura K; Asada K; Kusagaya H; Kaida Y; Matsuda H; Koshimizu N; Toyoshima M; Masuda M; Hayakawa H; Hozumi H; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Suda T
Int J Chron Obstruct Pulmon Dis; 2019; 14():1867-1877. PubMed ID: 31686799
[TBL] [Abstract][Full Text] [Related]
25. Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis.
Reddy HG; Schneider BJ; Tai AW
Clin Transl Gastroenterol; 2018 Sep; 9(9):180. PubMed ID: 30228268
[TBL] [Abstract][Full Text] [Related]
26. Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis.
Shah R; Cope JL; Nagy-Szakal D; Dowd S; Versalovic J; Hollister EB; Kellermayer R
Gut Microbes; 2016 Sep; 7(5):384-96. PubMed ID: 27217061
[TBL] [Abstract][Full Text] [Related]
27. Checkpoint inhibitor colitis: a new model of inflammatory bowel disease?
Siakavellas SI; Bamias G
Curr Opin Gastroenterol; 2018 Nov; 34(6):377-383. PubMed ID: 30157044
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies.
Chen JH; Pezhouh MK; Lauwers GY; Masia R
Am J Surg Pathol; 2017 May; 41(5):643-654. PubMed ID: 28296676
[TBL] [Abstract][Full Text] [Related]
29. Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing.
Wang YN; Meng XC; Dong YF; Zhao XH; Qian JM; Wang HY; Li JN
Chin Med J (Engl); 2019 Aug; 132(15):1833-1842. PubMed ID: 31268903
[TBL] [Abstract][Full Text] [Related]
30. Oral microbiome composition changes in mouse models of colitis.
Rautava J; Pinnell LJ; Vong L; Akseer N; Assa A; Sherman PM
J Gastroenterol Hepatol; 2015 Mar; 30(3):521-7. PubMed ID: 25180790
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic and histopathologic features of Anti-PD-1-related collagenous colitis.
Kikuchi H; Sakuraba H; Akemoto Y; Hosoi K; Murai Y; Hoshi K; Fukutoku Y; Asari T; Sawada Y; Hasui K; Tatsuta T; Hiraga H; Chinda D; Mikami T; Fukuda S
DEN Open; 2022 Apr; 2(1):e92. PubMed ID: 35310729
[TBL] [Abstract][Full Text] [Related]
32. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.
Ksienski D; Wai ES; Croteau N; Fiorino L; Brooks E; Poonja Z; Fenton D; Geller G; Glick D; Lesperance M
Clin Lung Cancer; 2019 Jan; 20(1):e97-e106. PubMed ID: 30337270
[TBL] [Abstract][Full Text] [Related]
34. Burn Injury Leads to Increase in Relative Abundance of Opportunistic Pathogens in the Rat Gastrointestinal Microbiome.
Huang G; Sun K; Yin S; Jiang B; Chen Y; Gong Y; Chen Y; Yang Z; Chen J; Yuan Z; Peng Y
Front Microbiol; 2017; 8():1237. PubMed ID: 28729860
[TBL] [Abstract][Full Text] [Related]
35. Effects of dietary nutrient levels on microbial community composition and diversity in the ileal contents of pregnant Huanjiang mini-pigs.
Ji Y; Kong X; Li H; Zhu Q; Guo Q; Yin Y
PLoS One; 2017; 12(2):e0172086. PubMed ID: 28196137
[TBL] [Abstract][Full Text] [Related]
36. Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.
Ohue Y; Kurose K; Karasaki T; Isobe M; Yamaoka T; Futami J; Irei I; Masuda T; Fukuda M; Kinoshita A; Matsushita H; Shimizu K; Nakata M; Hattori N; Yamaguchi H; Fukuda M; Nozawa R; Kakimi K; Oka M
J Thorac Oncol; 2019 Dec; 14(12):2071-2083. PubMed ID: 31449889
[TBL] [Abstract][Full Text] [Related]
37. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis.
Sun X; Roudi R; Dai T; Chen S; Fan B; Li H; Zhou Y; Zhou M; Zhu B; Yin C; Li B; Li X
BMC Cancer; 2019 Jun; 19(1):558. PubMed ID: 31182061
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
39. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
